RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $2.5B | +2.3% |
| Operating income | $1.5B | −0.5% |
| Net income | $815M | −4.6% |
| EPS | $1.88 | +6.2% |
Royalty Pharma plc
$57.16−0.47 (−0.82%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $2.5B | +2.3% |
| Operating income | $1.5B | −0.5% |
| Net income | $815M | −4.6% |
| EPS | $1.88 | +6.2% |